4//SEC Filing
Frelick Jeff 4
Accession 0001493152-24-003097
CIK 0001419554other
Filed
Jan 18, 7:00 PM ET
Accepted
Jan 19, 5:22 PM ET
Size
11.3 KB
Accession
0001493152-24-003097
Insider Transaction Report
Form 4
Frelick Jeff
Chief Executive Officer
Transactions
- Award
Employee Stock Option
2024-01-17+25,000→ 25,000 totalExercise: $3.61From: 2024-01-17Exp: 2026-01-17→ Common Stock (25,000 underlying)
Holdings
- 2,151
Common Stock
- 173
Employee Stock Option
Exercise: $9540.00Exp: 2025-12-27→ Common Stock (173 underlying) - 44
Employee Stock Option
Exercise: $12300.00Exp: 2026-05-26→ Common Stock (44 underlying) - 208
Employee Stock Option
Exercise: $892.80Exp: 2025-01-01→ Common Stock (208 underlying) - 157
Employee Stock Option
Exercise: $57.60Exp: 2025-01-25→ Common Stock (157 underlying)
Footnotes (2)
- [F1]This option was granted under the Bone Biologics Corporation 2015 Equity Incentive Plan, in a transaction exempt under Rule 16b-3 and, except as otherwise provided in the award notice, vests and becomes exercisable immediately.
- [F2]This option is fully vested as of the date of this report.
Documents
Issuer
Bone Biologics Corp
CIK 0001419554
Entity typeother
Related Parties
1- filerCIK 0001645093
Filing Metadata
- Form type
- 4
- Filed
- Jan 18, 7:00 PM ET
- Accepted
- Jan 19, 5:22 PM ET
- Size
- 11.3 KB